**Core Concept**
The maximum effect of bronchodilatation in asthma is related to the relaxation of bronchial smooth muscle, which is primarily mediated by beta-2 adrenergic receptors. This relaxation leads to an increase in airway diameter, facilitating airflow and improving lung function.

**Why the Correct Answer is Right**
The maximum effect of bronchodilatation in asthma is achieved through the stimulation of beta-2 adrenergic receptors (β2-ARs) in the bronchial smooth muscle. This is because β2-ARs are highly expressed in the bronchial smooth muscle and are responsible for mediating the relaxation of this muscle. When activated, β2-ARs activate adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels, which in turn activates protein kinase A (PKA). PKA then phosphorylates and relaxes the bronchial smooth muscle, resulting in bronchodilatation.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the maximum effect of bronchodilatation in asthma.
**Option B:** While β1-ARs are also adrenergic receptors, they are primarily found in the heart and are responsible for mediating the effects of beta-blockers, not bronchodilatation.
**Option C:** This option is not a type of adrenergic receptor and is therefore incorrect.

**Clinical Pearl / High-Yield Fact**
Beta-2 adrenergic agonists are the most effective bronchodilators in asthma due to their ability to selectively relax bronchial smooth muscle, leading to improved lung function and symptoms.

**Correct Answer: B. Beta-2 adrenergic receptors.**